The Regenerative Medicine Peptide Evidence Ladder for 2026
Not all regenerative medicine peptide claims are backed by the same level of science. This 2026 guide introduces an evidence ladder that ranks peptides by clinical maturity, from FDA-approved biologics to preclinical research compounds like BPC-157. Use it to separate verified data from marketing hype on any peptide claim you encounter.
Back Pain Stem Cell Therapy: Which Conditions It Treats in 2026
Back pain isn’t one condition, and stem cell therapy doesn’t work the same way for all of them. This guide breaks down five common diagnoses, from degenerative disc disease to spinal stenosis, to show where the evidence for back pain stem cell therapy is strongest in 2026.
Stem Cell Therapy and Diabetes: The 2026 Beta Cell Breakthrough
Stem cell therapy and diabetes research have reached a pivotal moment in 2026, with real beta cell replacement breakthroughs emerging alongside risky, unregulated clinic offerings. This article separates verified science from hype, helping patients understand what’s actually available, how close it is to approval, and what to watch out for.